PNC Financial Services Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-6,486
| Closed | -$340K | – | 4181 |
|
|
2020
Q3 | $340K | Sell |
6,486
-5,286
| -45% | -$219K | ﹤0.01% | 1600 |
|
|
2020
Q2 | $391K | Buy |
11,772
+846
| +8% | +$26.9K | ﹤0.01% | 1527 |
|
|
2020
Q1 | $297K | Sell |
10,926
-4,103
| -27% | -$114K | ﹤0.01% | 1589 |
|
|
2019
Q4 | $296K | Sell |
15,029
-2,471
| -14% | -$39.5K | ﹤0.01% | 1818 |
|
|
2019
Q3 | $227K | Sell |
17,500
-3,041
| -15% | -$36.7K | ﹤0.01% | 2070 |
|
|
2019
Q2 | $256K | Buy |
20,541
+1,554
| +8% | +$20.6K | ﹤0.01% | 2022 |
|
|
2019
Q1 | $275K | Buy |
18,987
+7,953
| +72% | +$102K | ﹤0.01% | 1957 |
|
|
2018
Q4 | $122K | Sell |
11,034
-56,963
| -84% | -$793K | ﹤0.01% | 2355 |
|
|
2018
Q3 | $1.79M | Buy |
67,997
+471
| +0.7% | +$12.7K | ﹤0.01% | 1108 |
|
|
2018
Q2 | $1.38M | Buy |
67,526
+65,921
| +4,107% | +$1.41M | ﹤0.01% | 1197 |
|
|
2018
Q1 | $29K | Buy |
1,605
+4
| +0.2% | +$67 | ﹤0.01% | 3260 |
|
|
2017
Q4 | $22K | Buy |
1,601
+844
| +111% | +$11.4K | ﹤0.01% | 3372 |
|
|
2017
Q3 | $14K | Sell |
757
-76,106
| -99% | -$1.27M | ﹤0.01% | 3561 |
|
|
2017
Q2 | $1.3M | Buy |
76,863
+303
| +0.4% | +$4.61K | ﹤0.01% | 1161 |
|
|
2017
Q1 | $1.02M | Sell |
76,560
-37,894
| -33% | -$594K | ﹤0.01% | 1284 |
|
|
2016
Q4 | $1.72M | Sell |
114,454
-2,439
| -2% | -$32.2K | ﹤0.01% | 1065 |
|
|
2016
Q3 | $1.37M | Sell |
116,893
-52,167
| -31% | -$613K | ﹤0.01% | 1145 |
|
|
2016
Q2 | $1.83M | Buy |
169,060
+4,791
| +3% | +$49.4K | ﹤0.01% | 981 |
|
|
2016
Q1 | $1.52M | Buy |
164,269
+163,932
| +48,645% | +$1.76M | ﹤0.01% | 1070 |
|
|
2015
Q4 | $5K | Hold |
337
| – | – | ﹤0.01% | 3895 |
|
|
2015
Q3 | $6K | Buy |
337
+11
| +3% | +$225 | ﹤0.01% | 3918 |
|
|
2015
Q2 | $7K | Buy |
326
+166
| +104% | +$3.31K | ﹤0.01% | 3962 |
|
|
2015
Q1 | $2K | Sell |
160
-400
| -71% | -$5.2K | ﹤0.01% | 4356 |
|
|
2014
Q4 | $6K | Buy |
560
+400
| +250% | +$4.57K | ﹤0.01% | 3521 |
|
|
2014
Q3 | $2K | Hold |
160
| – | – | ﹤0.01% | 3721 |
|
|
2014
Q2 | $2K | Hold |
160
| – | – | ﹤0.01% | 3578 |
|
|
2014
Q1 | $2K | Sell |
160
-450
| -74% | -$7.62K | ﹤0.01% | 3547 |
|
|
2013
Q4 | $11K | Buy |
+610
| New | +$10.3K | ﹤0.01% | 2969 |
|
PNC Financial Services Group's MNTA Position: Q4 2020 in Review
PNC Financial Services Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 6,486 shares — an estimated $340K sold.
PNC Financial Services Group first reported a position in MNTA in Q4 2013 and held it in 28 quarters. The position peaked at $1.83M in Q2 2016. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- PNC Financial Services Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- PNC Financial Services Group sold 6,486 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $340K.
- PNC Financial Services Group first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2013 and held it in 28 quarters.
- PNC Financial Services Group's Momenta Pharmaceuticals, Inc. position peaked at $1.83M in Q2 2016.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on PNC Financial Services Group's 13F filing for Q4 2020, filed 12 Feb 2021.